Dudediligence.

SCYNEXIS, Inc

SCYXNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

9.95M

on 2026-06-30, from 4.72M on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-8 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

2 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-10 is not read yet.

Cash

16.3 quarters

$54.1M on 2026-06-30 ÷ $3.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-03-30Private placement incl. 8.75M pre-funded43,500,000$0.92not stated8-K ↗

Also on file: a 1-for-8 reverse split, 2026-05-08 8-K ↗